Articles from BIOTECH Patent News (October 1, 2000)

1-47 out of 47 article(s)

Title	Type	Words
Affymetrix obtains United States patent.	Brief Article	57
Biogen applies for patent.	Brief Article	44
Biosource Technologies obtains United States patent.	Brief Article	55
Boston Scientific pays judgment from 1997 patent case.	Brief Article	121
Bristol-Myers Squibb applies for patent.		42
California Institute of Technology obtains United States patent.		49
Chiron and Roche agree to major diagnostic licensing terms.		1363
Chiron applies for patent.	Brief Article	41
D-Pharm receives prodrug technology patent.	Brief Article	415
Dana-Farber Cancer Institute obtains United States patent.	Brief Article	55
Demegen receives patent for plants producing antimicrobial peptides.	Brief Article	835
Elan obtains United States patent.	Brief Article	46
Genentech applies for patent.	Brief Article	39
Genentech obtains United States patent.	Brief Article	50
GeNeuron announces issuance of United States patent.	Brief Article	296
Genta announces licensing deal for antisense technology to Oasis Biosciences.	Brief Article	372
Glaxo Wellcome applies for patent.	Brief Article	43
Hollis-Eden expands its intellectual property position and acquires minority interest in Aeson Therapeutics.	Brief Article	941
Incyte obtains United States patent.	Brief Article	43
Johns Hopkins obtains United States patent.	Brief Article	93
KOSAN obtains United States patent.	Brief Article	51
Lexicon applies for patent.	Brief Article	35
Martek receives adverse ruling on European DHA patent.	Brief Article	291
Merial obtains United States patent.	Brief Article	53
Millenium obtains United States patent.	Brief Article	26
Millennium applies for patent.	Brief Article	44
Myriad Genetics awarded United States patent on P16 cancer protein and antibodies to protein.	Brief Article	377
Neose obtains United States patent.	Brief Article	29
Novo Nordisk obtains United States patent.	Brief Article	41
Oligos applies for patent.	Brief Article	53
Ortho-McNeil obtains United States patent.	Brief Article	40
Pilot Therapeutics receives United States patent on method of treating inflammatory disorders.	Brief Article	355
PPL Therapeutics applies for patent.		43
Sangamo applies for patent.	Brief Article	50
Schering-Plough exercises option to develop and commercialize one of Human Genome Sciences' discoveries.	Brief Article	301
SIBIA obtains United States patent.		43
Southern Biosystems announces collaboration with AstraZeneca.	Brief Article	202
State University of New York obtains United States patent.	Brief Article	48
Synaptic grants licenses to the R.W. Johnson Pharmaceutical Research Institute.	Brief Article	527
Thomas Jefferson University obtains United States patent.	Brief Article	40
Transgene receives patents covering homologous recombination technology in E. coli for fast generation of vectors.	Brief Article	384
University of Wisconsin applies for patent.	Brief Article	39
Utah State University obtains United States patent.	Brief Article	90
Valentis applies for patent.	Brief Article	54
Vertex Pharmaceuticals receives United States patent covering assay technology to accelerate drug discovery targeting hepatitis C protease.	Brief Article	962
Vical applies for patent.	Brief Article	40
Xencor applies for patent.	Brief Article	30